nodes	percent_of_prediction	percent_of_DWPC	metapath
Furosemide—CA9—kidney cancer	0.26	0.526	CbGaD
Furosemide—CA2—kidney cancer	0.233	0.473	CbGaD
Furosemide—SLC22A5—Dactinomycin—kidney cancer	0.0488	0.244	CbGbCtD
Furosemide—ABCC2—Paclitaxel—kidney cancer	0.0271	0.136	CbGbCtD
Furosemide—ABCC2—Sorafenib—kidney cancer	0.0241	0.121	CbGbCtD
Furosemide—ABCC2—Vinblastine—kidney cancer	0.0238	0.119	CbGbCtD
Furosemide—ABCC2—Vincristine—kidney cancer	0.0234	0.117	CbGbCtD
Furosemide—ABCC2—Sunitinib—kidney cancer	0.0195	0.0977	CbGbCtD
Furosemide—ALB—Erlotinib—kidney cancer	0.0185	0.0924	CbGbCtD
Furosemide—ABCC2—Doxorubicin—kidney cancer	0.0146	0.0732	CbGbCtD
Furosemide—SLC12A1—collecting duct of renal tubule—kidney cancer	0.0117	0.163	CbGeAlD
Furosemide—CA2—collecting duct of renal tubule—kidney cancer	0.0052	0.0728	CbGeAlD
Furosemide—SLC12A1—nephron—kidney cancer	0.00519	0.0727	CbGeAlD
Furosemide—SLC12A1—urine—kidney cancer	0.00416	0.0583	CbGeAlD
Furosemide—SLC22A8—nephron—kidney cancer	0.00301	0.0422	CbGeAlD
Furosemide—SLC22A8—urine—kidney cancer	0.00241	0.0338	CbGeAlD
Furosemide—SLC22A5—Temsirolimus—Everolimus—kidney cancer	0.00221	1	CbGdCrCtD
Furosemide—CA7—renal system—kidney cancer	0.00136	0.0191	CbGeAlD
Furosemide—CA7—kidney—kidney cancer	0.00132	0.0184	CbGeAlD
Furosemide—Indapamide—CA9—kidney cancer	0.00129	0.33	CrCbGaD
Furosemide—Indapamide—CA2—kidney cancer	0.00116	0.297	CrCbGaD
Furosemide—SLC22A11—nephron tubule—kidney cancer	0.00115	0.0161	CbGeAlD
Furosemide—Bumetanide—CA9—kidney cancer	0.00113	0.29	CrCbGaD
Furosemide—SLC12A1—nephron tubule—kidney cancer	0.00112	0.0157	CbGeAlD
Furosemide—SLC22A6—nephron tubule—kidney cancer	0.00109	0.0152	CbGeAlD
Furosemide—SLC22A11—renal system—kidney cancer	0.00105	0.0147	CbGeAlD
Furosemide—SLCO2A1—nephron tubule—kidney cancer	0.00103	0.0145	CbGeAlD
Furosemide—SLC12A1—renal system—kidney cancer	0.00102	0.0143	CbGeAlD
Furosemide—CA14—cardiac atrium—kidney cancer	0.00102	0.0142	CbGeAlD
Furosemide—SLC22A11—kidney—kidney cancer	0.00101	0.0142	CbGeAlD
Furosemide—SLC22A11—cortex of kidney—kidney cancer	0.000986	0.0138	CbGeAlD
Furosemide—SLC12A1—kidney—kidney cancer	0.000984	0.0138	CbGeAlD
Furosemide—SLC12A1—cortex of kidney—kidney cancer	0.000958	0.0134	CbGeAlD
Furosemide—SLCO2A1—renal system—kidney cancer	0.000939	0.0132	CbGeAlD
Furosemide—SLC22A6—cortex of kidney—kidney cancer	0.000929	0.013	CbGeAlD
Furosemide—PGD—nephron tubule—kidney cancer	0.000921	0.0129	CbGeAlD
Furosemide—SLCO2A1—kidney—kidney cancer	0.000908	0.0127	CbGeAlD
Furosemide—SLCO2A1—cortex of kidney—kidney cancer	0.000884	0.0124	CbGeAlD
Furosemide—CA12—renal system—kidney cancer	0.000884	0.0124	CbGeAlD
Furosemide—CA12—kidney—kidney cancer	0.000855	0.012	CbGeAlD
Furosemide—SLCO2A1—cardiac atrium—kidney cancer	0.000841	0.0118	CbGeAlD
Furosemide—PGD—renal system—kidney cancer	0.000837	0.0117	CbGeAlD
Furosemide—PGD—kidney—kidney cancer	0.000809	0.0113	CbGeAlD
Furosemide—PGD—cortex of kidney—kidney cancer	0.000788	0.011	CbGeAlD
Furosemide—PGD—gonad—kidney cancer	0.000751	0.0105	CbGeAlD
Furosemide—PGD—cardiac atrium—kidney cancer	0.00075	0.0105	CbGeAlD
Furosemide—CA5B—gonad—kidney cancer	0.000711	0.00996	CbGeAlD
Furosemide—CA5B—cardiac atrium—kidney cancer	0.00071	0.00995	CbGeAlD
Furosemide—CA1—renal system—kidney cancer	0.0007	0.00981	CbGeAlD
Furosemide—CA1—kidney—kidney cancer	0.000677	0.00949	CbGeAlD
Furosemide—SLC22A8—nephron tubule—kidney cancer	0.00065	0.0091	CbGeAlD
Furosemide—ABCC2—nephron tubule—kidney cancer	0.000634	0.00888	CbGeAlD
Furosemide—CA4—nephron tubule—kidney cancer	0.000602	0.00844	CbGeAlD
Furosemide—SLC22A8—renal system—kidney cancer	0.000591	0.00828	CbGeAlD
Furosemide—ABCC2—renal system—kidney cancer	0.000576	0.00808	CbGeAlD
Furosemide—SLC22A8—kidney—kidney cancer	0.000571	0.008	CbGeAlD
Furosemide—ABCC2—kidney—kidney cancer	0.000557	0.00781	CbGeAlD
Furosemide—SLC22A8—cortex of kidney—kidney cancer	0.000556	0.00779	CbGeAlD
Furosemide—CA4—renal system—kidney cancer	0.000547	0.00767	CbGeAlD
Furosemide—ABCC2—cortex of kidney—kidney cancer	0.000543	0.0076	CbGeAlD
Furosemide—CA4—kidney—kidney cancer	0.000529	0.00741	CbGeAlD
Furosemide—CA4—cortex of kidney—kidney cancer	0.000515	0.00722	CbGeAlD
Furosemide—CA2—nephron tubule—kidney cancer	0.000499	0.007	CbGeAlD
Furosemide—SLC22A5—nephron tubule—kidney cancer	0.000491	0.00688	CbGeAlD
Furosemide—CA4—cardiac atrium—kidney cancer	0.00049	0.00687	CbGeAlD
Furosemide—CA2—renal system—kidney cancer	0.000454	0.00636	CbGeAlD
Furosemide—SLC22A5—renal system—kidney cancer	0.000447	0.00626	CbGeAlD
Furosemide—CA2—kidney—kidney cancer	0.000439	0.00615	CbGeAlD
Furosemide—SLC22A5—kidney—kidney cancer	0.000432	0.00605	CbGeAlD
Furosemide—CA2—cortex of kidney—kidney cancer	0.000427	0.00599	CbGeAlD
Furosemide—SLC22A5—cortex of kidney—kidney cancer	0.00042	0.00589	CbGeAlD
Furosemide—CA2—cardiac atrium—kidney cancer	0.000407	0.00569	CbGeAlD
Furosemide—SLC22A5—cardiac atrium—kidney cancer	0.0004	0.0056	CbGeAlD
Furosemide—Bumetanide—PTGS2—kidney cancer	0.00032	0.0819	CrCbGaD
Furosemide—Diarrhoea—Erlotinib—kidney cancer	0.000106	0.000751	CcSEcCtD
Furosemide—Hypotension—Vincristine—kidney cancer	0.000106	0.000751	CcSEcCtD
Furosemide—Nervous system disorder—Gemcitabine—kidney cancer	0.000105	0.000748	CcSEcCtD
Furosemide—Thrombocytopenia—Gemcitabine—kidney cancer	0.000105	0.000746	CcSEcCtD
Furosemide—Feeling abnormal—Dactinomycin—kidney cancer	0.000104	0.000741	CcSEcCtD
Furosemide—Skin disorder—Gemcitabine—kidney cancer	0.000104	0.000741	CcSEcCtD
Furosemide—Vision blurred—Paclitaxel—kidney cancer	0.000104	0.000737	CcSEcCtD
Furosemide—Hyperhidrosis—Gemcitabine—kidney cancer	0.000104	0.000737	CcSEcCtD
Furosemide—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000104	0.000736	CcSEcCtD
Furosemide—Urinary tract disorder—Capecitabine—kidney cancer	0.000103	0.000728	CcSEcCtD
Furosemide—Dermatitis exfoliative—Doxorubicin—kidney cancer	0.000103	0.000728	CcSEcCtD
Furosemide—Hypersensitivity—Sorafenib—kidney cancer	0.000103	0.000727	CcSEcCtD
Furosemide—Anorexia—Gemcitabine—kidney cancer	0.000102	0.000727	CcSEcCtD
Furosemide—Vomiting—Vinblastine—kidney cancer	0.000102	0.000726	CcSEcCtD
Furosemide—Dizziness—Erlotinib—kidney cancer	0.000102	0.000726	CcSEcCtD
Furosemide—Vomiting—Everolimus—kidney cancer	0.000102	0.000723	CcSEcCtD
Furosemide—Anaemia—Paclitaxel—kidney cancer	0.000102	0.000723	CcSEcCtD
Furosemide—Urethral disorder—Capecitabine—kidney cancer	0.000102	0.000723	CcSEcCtD
Furosemide—Paraesthesia—Vincristine—kidney cancer	0.000102	0.000722	CcSEcCtD
Furosemide—Dermatitis bullous—Doxorubicin—kidney cancer	0.000101	0.000719	CcSEcCtD
Furosemide—Agitation—Paclitaxel—kidney cancer	0.000101	0.000719	CcSEcCtD
Furosemide—Rash—Everolimus—kidney cancer	0.000101	0.000717	CcSEcCtD
Furosemide—Dermatitis—Everolimus—kidney cancer	0.000101	0.000717	CcSEcCtD
Furosemide—Headache—Vinblastine—kidney cancer	0.000101	0.000715	CcSEcCtD
Furosemide—Purpura—Doxorubicin—kidney cancer	0.0001	0.000713	CcSEcCtD
Furosemide—Headache—Everolimus—kidney cancer	0.0001	0.000713	CcSEcCtD
Furosemide—Hypotension—Gemcitabine—kidney cancer	0.0001	0.000712	CcSEcCtD
Furosemide—Body temperature increased—Dactinomycin—kidney cancer	0.0001	0.000711	CcSEcCtD
Furosemide—Abdominal pain—Dactinomycin—kidney cancer	0.0001	0.000711	CcSEcCtD
Furosemide—Visual impairment—Capecitabine—kidney cancer	0.0001	0.000711	CcSEcCtD
Furosemide—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.0001	0.00071	CcSEcCtD
Furosemide—Asthenia—Sorafenib—kidney cancer	9.98e-05	0.000708	CcSEcCtD
Furosemide—Vertigo—Paclitaxel—kidney cancer	9.9e-05	0.000703	CcSEcCtD
Furosemide—Lethargy—Doxorubicin—kidney cancer	9.88e-05	0.000701	CcSEcCtD
Furosemide—Leukopenia—Paclitaxel—kidney cancer	9.86e-05	0.0007	CcSEcCtD
Furosemide—Hypersensitivity—Sunitinib—kidney cancer	9.86e-05	0.0007	CcSEcCtD
Furosemide—Decreased appetite—Vincristine—kidney cancer	9.84e-05	0.000699	CcSEcCtD
Furosemide—Pruritus—Sorafenib—kidney cancer	9.84e-05	0.000699	CcSEcCtD
Furosemide—Vomiting—Erlotinib—kidney cancer	9.83e-05	0.000698	CcSEcCtD
Furosemide—Erythema multiforme—Capecitabine—kidney cancer	9.82e-05	0.000697	CcSEcCtD
Furosemide—Gastrointestinal disorder—Vincristine—kidney cancer	9.78e-05	0.000694	CcSEcCtD
Furosemide—Fatigue—Vincristine—kidney cancer	9.76e-05	0.000693	CcSEcCtD
Furosemide—Rash—Erlotinib—kidney cancer	9.75e-05	0.000692	CcSEcCtD
Furosemide—Dermatitis—Erlotinib—kidney cancer	9.74e-05	0.000691	CcSEcCtD
Furosemide—Hyponatraemia—Doxorubicin—kidney cancer	9.72e-05	0.00069	CcSEcCtD
Furosemide—Eye disorder—Capecitabine—kidney cancer	9.71e-05	0.000689	CcSEcCtD
Furosemide—Headache—Erlotinib—kidney cancer	9.69e-05	0.000688	CcSEcCtD
Furosemide—Tinnitus—Capecitabine—kidney cancer	9.69e-05	0.000687	CcSEcCtD
Furosemide—Constipation—Vincristine—kidney cancer	9.68e-05	0.000687	CcSEcCtD
Furosemide—Pain—Vincristine—kidney cancer	9.68e-05	0.000687	CcSEcCtD
Furosemide—Paraesthesia—Gemcitabine—kidney cancer	9.65e-05	0.000685	CcSEcCtD
Furosemide—Asthenia—Sunitinib—kidney cancer	9.61e-05	0.000682	CcSEcCtD
Furosemide—Nausea—Vinblastine—kidney cancer	9.56e-05	0.000678	CcSEcCtD
Furosemide—Somnolence—Gemcitabine—kidney cancer	9.55e-05	0.000678	CcSEcCtD
Furosemide—Nausea—Everolimus—kidney cancer	9.52e-05	0.000676	CcSEcCtD
Furosemide—Diarrhoea—Sorafenib—kidney cancer	9.52e-05	0.000676	CcSEcCtD
Furosemide—Pruritus—Sunitinib—kidney cancer	9.47e-05	0.000672	CcSEcCtD
Furosemide—Angiopathy—Capecitabine—kidney cancer	9.43e-05	0.000669	CcSEcCtD
Furosemide—Immune system disorder—Capecitabine—kidney cancer	9.38e-05	0.000666	CcSEcCtD
Furosemide—Decreased appetite—Gemcitabine—kidney cancer	9.34e-05	0.000663	CcSEcCtD
Furosemide—Hypersensitivity—Dactinomycin—kidney cancer	9.34e-05	0.000663	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	9.32e-05	0.000661	CcSEcCtD
Furosemide—Arrhythmia—Capecitabine—kidney cancer	9.28e-05	0.000659	CcSEcCtD
Furosemide—Gastrointestinal disorder—Gemcitabine—kidney cancer	9.27e-05	0.000658	CcSEcCtD
Furosemide—Fatigue—Gemcitabine—kidney cancer	9.26e-05	0.000657	CcSEcCtD
Furosemide—Gastrointestinal pain—Vincristine—kidney cancer	9.26e-05	0.000657	CcSEcCtD
Furosemide—Dizziness—Sorafenib—kidney cancer	9.2e-05	0.000653	CcSEcCtD
Furosemide—Pain—Gemcitabine—kidney cancer	9.19e-05	0.000652	CcSEcCtD
Furosemide—Constipation—Gemcitabine—kidney cancer	9.19e-05	0.000652	CcSEcCtD
Furosemide—Nausea—Erlotinib—kidney cancer	9.19e-05	0.000652	CcSEcCtD
Furosemide—Dry mouth—Paclitaxel—kidney cancer	9.18e-05	0.000651	CcSEcCtD
Furosemide—Diarrhoea—Sunitinib—kidney cancer	9.16e-05	0.00065	CcSEcCtD
Furosemide—Asthenia—Dactinomycin—kidney cancer	9.09e-05	0.000645	CcSEcCtD
Furosemide—Confusional state—Paclitaxel—kidney cancer	9.07e-05	0.000644	CcSEcCtD
Furosemide—Blood creatinine increased—Doxorubicin—kidney cancer	9.07e-05	0.000644	CcSEcCtD
Furosemide—Erythema—Capecitabine—kidney cancer	9.04e-05	0.000642	CcSEcCtD
Furosemide—Malnutrition—Capecitabine—kidney cancer	9.04e-05	0.000642	CcSEcCtD
Furosemide—Dehydration—Doxorubicin—kidney cancer	9e-05	0.000639	CcSEcCtD
Furosemide—Anaphylactic shock—Paclitaxel—kidney cancer	8.99e-05	0.000638	CcSEcCtD
Furosemide—Body temperature increased—Vincristine—kidney cancer	8.95e-05	0.000635	CcSEcCtD
Furosemide—Abdominal pain—Vincristine—kidney cancer	8.95e-05	0.000635	CcSEcCtD
Furosemide—Flatulence—Capecitabine—kidney cancer	8.91e-05	0.000632	CcSEcCtD
Furosemide—Dysgeusia—Capecitabine—kidney cancer	8.86e-05	0.000629	CcSEcCtD
Furosemide—Dizziness—Sunitinib—kidney cancer	8.85e-05	0.000628	CcSEcCtD
Furosemide—Feeling abnormal—Gemcitabine—kidney cancer	8.85e-05	0.000628	CcSEcCtD
Furosemide—Shock—Paclitaxel—kidney cancer	8.85e-05	0.000628	CcSEcCtD
Furosemide—Vomiting—Sorafenib—kidney cancer	8.85e-05	0.000628	CcSEcCtD
Furosemide—Orthostatic hypotension—Doxorubicin—kidney cancer	8.84e-05	0.000627	CcSEcCtD
Furosemide—Nervous system disorder—Paclitaxel—kidney cancer	8.82e-05	0.000626	CcSEcCtD
Furosemide—Hypokalaemia—Doxorubicin—kidney cancer	8.81e-05	0.000625	CcSEcCtD
Furosemide—Thrombocytopenia—Paclitaxel—kidney cancer	8.81e-05	0.000625	CcSEcCtD
Furosemide—Rash—Sorafenib—kidney cancer	8.77e-05	0.000623	CcSEcCtD
Furosemide—Dermatitis—Sorafenib—kidney cancer	8.76e-05	0.000622	CcSEcCtD
Furosemide—Skin disorder—Paclitaxel—kidney cancer	8.74e-05	0.00062	CcSEcCtD
Furosemide—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	8.72e-05	0.000619	CcSEcCtD
Furosemide—Headache—Sorafenib—kidney cancer	8.72e-05	0.000619	CcSEcCtD
Furosemide—Muscle spasms—Capecitabine—kidney cancer	8.7e-05	0.000617	CcSEcCtD
Furosemide—Hyperhidrosis—Paclitaxel—kidney cancer	8.7e-05	0.000617	CcSEcCtD
Furosemide—Diarrhoea—Dactinomycin—kidney cancer	8.67e-05	0.000615	CcSEcCtD
Furosemide—Anorexia—Paclitaxel—kidney cancer	8.57e-05	0.000608	CcSEcCtD
Furosemide—Muscular weakness—Doxorubicin—kidney cancer	8.54e-05	0.000606	CcSEcCtD
Furosemide—Vision blurred—Capecitabine—kidney cancer	8.52e-05	0.000605	CcSEcCtD
Furosemide—Vomiting—Sunitinib—kidney cancer	8.51e-05	0.000604	CcSEcCtD
Furosemide—Body temperature increased—Gemcitabine—kidney cancer	8.49e-05	0.000603	CcSEcCtD
Furosemide—Rash—Sunitinib—kidney cancer	8.44e-05	0.000599	CcSEcCtD
Furosemide—Dermatitis—Sunitinib—kidney cancer	8.43e-05	0.000599	CcSEcCtD
Furosemide—Abdominal distension—Doxorubicin—kidney cancer	8.42e-05	0.000598	CcSEcCtD
Furosemide—Hypotension—Paclitaxel—kidney cancer	8.4e-05	0.000596	CcSEcCtD
Furosemide—Headache—Sunitinib—kidney cancer	8.39e-05	0.000595	CcSEcCtD
Furosemide—Anaemia—Capecitabine—kidney cancer	8.36e-05	0.000593	CcSEcCtD
Furosemide—Hypersensitivity—Vincristine—kidney cancer	8.34e-05	0.000592	CcSEcCtD
Furosemide—Eosinophilia—Doxorubicin—kidney cancer	8.28e-05	0.000588	CcSEcCtD
Furosemide—Nausea—Sorafenib—kidney cancer	8.26e-05	0.000587	CcSEcCtD
Furosemide—Pancreatitis—Doxorubicin—kidney cancer	8.2e-05	0.000582	CcSEcCtD
Furosemide—Vertigo—Capecitabine—kidney cancer	8.13e-05	0.000577	CcSEcCtD
Furosemide—Asthenia—Vincristine—kidney cancer	8.12e-05	0.000577	CcSEcCtD
Furosemide—Leukopenia—Capecitabine—kidney cancer	8.1e-05	0.000575	CcSEcCtD
Furosemide—Paraesthesia—Paclitaxel—kidney cancer	8.08e-05	0.000573	CcSEcCtD
Furosemide—Vomiting—Dactinomycin—kidney cancer	8.06e-05	0.000572	CcSEcCtD
Furosemide—Somnolence—Paclitaxel—kidney cancer	8e-05	0.000567	CcSEcCtD
Furosemide—Rash—Dactinomycin—kidney cancer	7.99e-05	0.000567	CcSEcCtD
Furosemide—Nausea—Sunitinib—kidney cancer	7.95e-05	0.000564	CcSEcCtD
Furosemide—Decreased appetite—Paclitaxel—kidney cancer	7.82e-05	0.000555	CcSEcCtD
Furosemide—Gastrointestinal disorder—Paclitaxel—kidney cancer	7.77e-05	0.000551	CcSEcCtD
Furosemide—Fatigue—Paclitaxel—kidney cancer	7.75e-05	0.00055	CcSEcCtD
Furosemide—Diarrhoea—Vincristine—kidney cancer	7.75e-05	0.00055	CcSEcCtD
Furosemide—Pollakiuria—Doxorubicin—kidney cancer	7.73e-05	0.000549	CcSEcCtD
Furosemide—Asthenia—Gemcitabine—kidney cancer	7.71e-05	0.000547	CcSEcCtD
Furosemide—Pain—Paclitaxel—kidney cancer	7.69e-05	0.000546	CcSEcCtD
Furosemide—Constipation—Paclitaxel—kidney cancer	7.69e-05	0.000546	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	7.65e-05	0.000543	CcSEcCtD
Furosemide—Photosensitivity reaction—Doxorubicin—kidney cancer	7.64e-05	0.000542	CcSEcCtD
Furosemide—Pruritus—Gemcitabine—kidney cancer	7.6e-05	0.000539	CcSEcCtD
Furosemide—Hyperglycaemia—Doxorubicin—kidney cancer	7.55e-05	0.000536	CcSEcCtD
Furosemide—Dry mouth—Capecitabine—kidney cancer	7.53e-05	0.000534	CcSEcCtD
Furosemide—Nausea—Dactinomycin—kidney cancer	7.53e-05	0.000534	CcSEcCtD
Furosemide—Dizziness—Vincristine—kidney cancer	7.49e-05	0.000531	CcSEcCtD
Furosemide—Drowsiness—Doxorubicin—kidney cancer	7.46e-05	0.000529	CcSEcCtD
Furosemide—Confusional state—Capecitabine—kidney cancer	7.44e-05	0.000528	CcSEcCtD
Furosemide—Feeling abnormal—Paclitaxel—kidney cancer	7.41e-05	0.000526	CcSEcCtD
Furosemide—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	7.4e-05	0.000525	CcSEcCtD
Furosemide—Gastrointestinal pain—Paclitaxel—kidney cancer	7.35e-05	0.000522	CcSEcCtD
Furosemide—Diarrhoea—Gemcitabine—kidney cancer	7.35e-05	0.000522	CcSEcCtD
Furosemide—Renal failure—Doxorubicin—kidney cancer	7.33e-05	0.00052	CcSEcCtD
Furosemide—Shock—Capecitabine—kidney cancer	7.26e-05	0.000515	CcSEcCtD
Furosemide—Nervous system disorder—Capecitabine—kidney cancer	7.24e-05	0.000514	CcSEcCtD
Furosemide—Thrombocytopenia—Capecitabine—kidney cancer	7.23e-05	0.000513	CcSEcCtD
Furosemide—Vomiting—Vincristine—kidney cancer	7.2e-05	0.000511	CcSEcCtD
Furosemide—Skin disorder—Capecitabine—kidney cancer	7.17e-05	0.000509	CcSEcCtD
Furosemide—Sweating—Doxorubicin—kidney cancer	7.15e-05	0.000508	CcSEcCtD
Furosemide—Urticaria—Paclitaxel—kidney cancer	7.15e-05	0.000507	CcSEcCtD
Furosemide—Rash—Vincristine—kidney cancer	7.14e-05	0.000507	CcSEcCtD
Furosemide—Hyperhidrosis—Capecitabine—kidney cancer	7.14e-05	0.000506	CcSEcCtD
Furosemide—Dermatitis—Vincristine—kidney cancer	7.13e-05	0.000506	CcSEcCtD
Furosemide—Abdominal pain—Paclitaxel—kidney cancer	7.11e-05	0.000505	CcSEcCtD
Furosemide—Body temperature increased—Paclitaxel—kidney cancer	7.11e-05	0.000505	CcSEcCtD
Furosemide—Headache—Vincristine—kidney cancer	7.09e-05	0.000503	CcSEcCtD
Furosemide—Hepatobiliary disease—Doxorubicin—kidney cancer	7.06e-05	0.000501	CcSEcCtD
Furosemide—Anorexia—Capecitabine—kidney cancer	7.04e-05	0.000499	CcSEcCtD
Furosemide—Agranulocytosis—Doxorubicin—kidney cancer	6.96e-05	0.000494	CcSEcCtD
Furosemide—Hypotension—Capecitabine—kidney cancer	6.9e-05	0.000489	CcSEcCtD
Furosemide—Vomiting—Gemcitabine—kidney cancer	6.83e-05	0.000485	CcSEcCtD
Furosemide—Rash—Gemcitabine—kidney cancer	6.77e-05	0.000481	CcSEcCtD
Furosemide—Dermatitis—Gemcitabine—kidney cancer	6.77e-05	0.00048	CcSEcCtD
Furosemide—Headache—Gemcitabine—kidney cancer	6.73e-05	0.000478	CcSEcCtD
Furosemide—Nausea—Vincristine—kidney cancer	6.73e-05	0.000477	CcSEcCtD
Furosemide—Paraesthesia—Capecitabine—kidney cancer	6.63e-05	0.00047	CcSEcCtD
Furosemide—Hypersensitivity—Paclitaxel—kidney cancer	6.63e-05	0.00047	CcSEcCtD
Furosemide—Urinary tract disorder—Doxorubicin—kidney cancer	6.61e-05	0.000469	CcSEcCtD
Furosemide—Urethral disorder—Doxorubicin—kidney cancer	6.56e-05	0.000466	CcSEcCtD
Furosemide—Visual impairment—Doxorubicin—kidney cancer	6.45e-05	0.000458	CcSEcCtD
Furosemide—Asthenia—Paclitaxel—kidney cancer	6.45e-05	0.000458	CcSEcCtD
Furosemide—Decreased appetite—Capecitabine—kidney cancer	6.42e-05	0.000455	CcSEcCtD
Furosemide—Nausea—Gemcitabine—kidney cancer	6.38e-05	0.000453	CcSEcCtD
Furosemide—Gastrointestinal disorder—Capecitabine—kidney cancer	6.37e-05	0.000452	CcSEcCtD
Furosemide—Fatigue—Capecitabine—kidney cancer	6.36e-05	0.000452	CcSEcCtD
Furosemide—Pruritus—Paclitaxel—kidney cancer	6.36e-05	0.000452	CcSEcCtD
Furosemide—Erythema multiforme—Doxorubicin—kidney cancer	6.33e-05	0.000449	CcSEcCtD
Furosemide—Constipation—Capecitabine—kidney cancer	6.31e-05	0.000448	CcSEcCtD
Furosemide—Pain—Capecitabine—kidney cancer	6.31e-05	0.000448	CcSEcCtD
Furosemide—Eye disorder—Doxorubicin—kidney cancer	6.26e-05	0.000444	CcSEcCtD
Furosemide—Tinnitus—Doxorubicin—kidney cancer	6.24e-05	0.000443	CcSEcCtD
Furosemide—Diarrhoea—Paclitaxel—kidney cancer	6.15e-05	0.000437	CcSEcCtD
Furosemide—Feeling abnormal—Capecitabine—kidney cancer	6.08e-05	0.000432	CcSEcCtD
Furosemide—Angiopathy—Doxorubicin—kidney cancer	6.08e-05	0.000431	CcSEcCtD
Furosemide—Immune system disorder—Doxorubicin—kidney cancer	6.05e-05	0.000429	CcSEcCtD
Furosemide—Gastrointestinal pain—Capecitabine—kidney cancer	6.04e-05	0.000428	CcSEcCtD
Furosemide—Arrhythmia—Doxorubicin—kidney cancer	5.98e-05	0.000425	CcSEcCtD
Furosemide—Dizziness—Paclitaxel—kidney cancer	5.95e-05	0.000422	CcSEcCtD
Furosemide—Urticaria—Capecitabine—kidney cancer	5.86e-05	0.000416	CcSEcCtD
Furosemide—Abdominal pain—Capecitabine—kidney cancer	5.83e-05	0.000414	CcSEcCtD
Furosemide—Body temperature increased—Capecitabine—kidney cancer	5.83e-05	0.000414	CcSEcCtD
Furosemide—Malnutrition—Doxorubicin—kidney cancer	5.83e-05	0.000414	CcSEcCtD
Furosemide—Erythema—Doxorubicin—kidney cancer	5.83e-05	0.000414	CcSEcCtD
Furosemide—Flatulence—Doxorubicin—kidney cancer	5.74e-05	0.000408	CcSEcCtD
Furosemide—Vomiting—Paclitaxel—kidney cancer	5.72e-05	0.000406	CcSEcCtD
Furosemide—Dysgeusia—Doxorubicin—kidney cancer	5.71e-05	0.000405	CcSEcCtD
Furosemide—Rash—Paclitaxel—kidney cancer	5.67e-05	0.000402	CcSEcCtD
Furosemide—Dermatitis—Paclitaxel—kidney cancer	5.67e-05	0.000402	CcSEcCtD
Furosemide—Headache—Paclitaxel—kidney cancer	5.63e-05	0.0004	CcSEcCtD
Furosemide—Muscle spasms—Doxorubicin—kidney cancer	5.6e-05	0.000398	CcSEcCtD
Furosemide—Vision blurred—Doxorubicin—kidney cancer	5.49e-05	0.00039	CcSEcCtD
Furosemide—Hypersensitivity—Capecitabine—kidney cancer	5.44e-05	0.000386	CcSEcCtD
Furosemide—Anaemia—Doxorubicin—kidney cancer	5.39e-05	0.000382	CcSEcCtD
Furosemide—Agitation—Doxorubicin—kidney cancer	5.36e-05	0.00038	CcSEcCtD
Furosemide—Nausea—Paclitaxel—kidney cancer	5.34e-05	0.000379	CcSEcCtD
Furosemide—Asthenia—Capecitabine—kidney cancer	5.3e-05	0.000376	CcSEcCtD
Furosemide—Vertigo—Doxorubicin—kidney cancer	5.24e-05	0.000372	CcSEcCtD
Furosemide—Pruritus—Capecitabine—kidney cancer	5.22e-05	0.000371	CcSEcCtD
Furosemide—Leukopenia—Doxorubicin—kidney cancer	5.22e-05	0.00037	CcSEcCtD
Furosemide—Diarrhoea—Capecitabine—kidney cancer	5.05e-05	0.000358	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	4.93e-05	0.00035	CcSEcCtD
Furosemide—Dizziness—Capecitabine—kidney cancer	4.88e-05	0.000346	CcSEcCtD
Furosemide—Dry mouth—Doxorubicin—kidney cancer	4.85e-05	0.000344	CcSEcCtD
Furosemide—Confusional state—Doxorubicin—kidney cancer	4.8e-05	0.00034	CcSEcCtD
Furosemide—Anaphylactic shock—Doxorubicin—kidney cancer	4.76e-05	0.000338	CcSEcCtD
Furosemide—Vomiting—Capecitabine—kidney cancer	4.69e-05	0.000333	CcSEcCtD
Furosemide—Shock—Doxorubicin—kidney cancer	4.68e-05	0.000332	CcSEcCtD
Furosemide—Nervous system disorder—Doxorubicin—kidney cancer	4.67e-05	0.000331	CcSEcCtD
Furosemide—Thrombocytopenia—Doxorubicin—kidney cancer	4.66e-05	0.000331	CcSEcCtD
Furosemide—Rash—Capecitabine—kidney cancer	4.65e-05	0.00033	CcSEcCtD
Furosemide—Dermatitis—Capecitabine—kidney cancer	4.65e-05	0.00033	CcSEcCtD
Furosemide—Headache—Capecitabine—kidney cancer	4.62e-05	0.000328	CcSEcCtD
Furosemide—Skin disorder—Doxorubicin—kidney cancer	4.62e-05	0.000328	CcSEcCtD
Furosemide—Hyperhidrosis—Doxorubicin—kidney cancer	4.6e-05	0.000326	CcSEcCtD
Furosemide—Anorexia—Doxorubicin—kidney cancer	4.54e-05	0.000322	CcSEcCtD
Furosemide—Hypotension—Doxorubicin—kidney cancer	4.45e-05	0.000316	CcSEcCtD
Furosemide—Nausea—Capecitabine—kidney cancer	4.38e-05	0.000311	CcSEcCtD
Furosemide—Paraesthesia—Doxorubicin—kidney cancer	4.27e-05	0.000303	CcSEcCtD
Furosemide—Somnolence—Doxorubicin—kidney cancer	4.23e-05	0.0003	CcSEcCtD
Furosemide—Decreased appetite—Doxorubicin—kidney cancer	4.14e-05	0.000294	CcSEcCtD
Furosemide—Gastrointestinal disorder—Doxorubicin—kidney cancer	4.11e-05	0.000292	CcSEcCtD
Furosemide—Fatigue—Doxorubicin—kidney cancer	4.1e-05	0.000291	CcSEcCtD
Furosemide—Pain—Doxorubicin—kidney cancer	4.07e-05	0.000289	CcSEcCtD
Furosemide—Constipation—Doxorubicin—kidney cancer	4.07e-05	0.000289	CcSEcCtD
Furosemide—Feeling abnormal—Doxorubicin—kidney cancer	3.92e-05	0.000278	CcSEcCtD
Furosemide—Gastrointestinal pain—Doxorubicin—kidney cancer	3.89e-05	0.000276	CcSEcCtD
Furosemide—Urticaria—Doxorubicin—kidney cancer	3.78e-05	0.000268	CcSEcCtD
Furosemide—Abdominal pain—Doxorubicin—kidney cancer	3.76e-05	0.000267	CcSEcCtD
Furosemide—Body temperature increased—Doxorubicin—kidney cancer	3.76e-05	0.000267	CcSEcCtD
Furosemide—Hypersensitivity—Doxorubicin—kidney cancer	3.51e-05	0.000249	CcSEcCtD
Furosemide—Asthenia—Doxorubicin—kidney cancer	3.41e-05	0.000242	CcSEcCtD
Furosemide—Pruritus—Doxorubicin—kidney cancer	3.37e-05	0.000239	CcSEcCtD
Furosemide—Diarrhoea—Doxorubicin—kidney cancer	3.26e-05	0.000231	CcSEcCtD
Furosemide—Dizziness—Doxorubicin—kidney cancer	3.15e-05	0.000223	CcSEcCtD
Furosemide—Vomiting—Doxorubicin—kidney cancer	3.03e-05	0.000215	CcSEcCtD
Furosemide—Rash—Doxorubicin—kidney cancer	3e-05	0.000213	CcSEcCtD
Furosemide—Dermatitis—Doxorubicin—kidney cancer	3e-05	0.000213	CcSEcCtD
Furosemide—Headache—Doxorubicin—kidney cancer	2.98e-05	0.000212	CcSEcCtD
Furosemide—Nausea—Doxorubicin—kidney cancer	2.83e-05	0.000201	CcSEcCtD
Furosemide—CA4—Metabolism—ITPR2—kidney cancer	2.67e-05	0.000302	CbGpPWpGaD
Furosemide—CA12—Metabolism—BCHE—kidney cancer	2.66e-05	0.000301	CbGpPWpGaD
Furosemide—CA9—Cellular responses to stress—JUN—kidney cancer	2.65e-05	0.000299	CbGpPWpGaD
Furosemide—CA1—Metabolism—CRABP1—kidney cancer	2.64e-05	0.000299	CbGpPWpGaD
Furosemide—CA12—Metabolism—SLC5A5—kidney cancer	2.63e-05	0.000297	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—SLC5A5—kidney cancer	2.6e-05	0.000294	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.6e-05	0.000294	CbGpPWpGaD
Furosemide—ALB—Folate Metabolism—IL2—kidney cancer	2.57e-05	0.000291	CbGpPWpGaD
Furosemide—CA2—Metabolism—ITPR2—kidney cancer	2.56e-05	0.00029	CbGpPWpGaD
Furosemide—CA12—Metabolism—SLC2A1—kidney cancer	2.54e-05	0.000287	CbGpPWpGaD
Furosemide—CA14—Metabolism—GSTP1—kidney cancer	2.52e-05	0.000284	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—SLC2A1—kidney cancer	2.51e-05	0.000284	CbGpPWpGaD
Furosemide—ALB—Hemostasis—ANXA2—kidney cancer	2.47e-05	0.000279	CbGpPWpGaD
Furosemide—SLC12A1—Transmembrane transport of small molecules—RAF1—kidney cancer	2.47e-05	0.000279	CbGpPWpGaD
Furosemide—CA1—Metabolism—ITPR2—kidney cancer	2.46e-05	0.000278	CbGpPWpGaD
Furosemide—CA6—Metabolism—GSTP1—kidney cancer	2.45e-05	0.000277	CbGpPWpGaD
Furosemide—CA5A—Metabolism—GSTP1—kidney cancer	2.45e-05	0.000277	CbGpPWpGaD
Furosemide—CA4—Metabolism—ACHE—kidney cancer	2.44e-05	0.000276	CbGpPWpGaD
Furosemide—CA4—Metabolism—GSTT1—kidney cancer	2.44e-05	0.000276	CbGpPWpGaD
Furosemide—CA14—Metabolism—ABCB1—kidney cancer	2.38e-05	0.000269	CbGpPWpGaD
Furosemide—PGD—Metabolism—GSTP1—kidney cancer	2.37e-05	0.000267	CbGpPWpGaD
Furosemide—CA2—Metabolism—GSTT1—kidney cancer	2.34e-05	0.000264	CbGpPWpGaD
Furosemide—CA2—Metabolism—ACHE—kidney cancer	2.34e-05	0.000264	CbGpPWpGaD
Furosemide—CA9—Metabolism—CRABP1—kidney cancer	2.32e-05	0.000263	CbGpPWpGaD
Furosemide—CA6—Metabolism—ABCB1—kidney cancer	2.32e-05	0.000262	CbGpPWpGaD
Furosemide—CA5A—Metabolism—ABCB1—kidney cancer	2.32e-05	0.000262	CbGpPWpGaD
Furosemide—CA9—Cellular responses to stress—VEGFA—kidney cancer	2.31e-05	0.000261	CbGpPWpGaD
Furosemide—CA14—Metabolism—GSTM1—kidney cancer	2.31e-05	0.000261	CbGpPWpGaD
Furosemide—CA4—Metabolism—SCARB1—kidney cancer	2.31e-05	0.000261	CbGpPWpGaD
Furosemide—CA5B—Metabolism—GSTP1—kidney cancer	2.29e-05	0.000258	CbGpPWpGaD
Furosemide—CA7—Metabolism—GSTP1—kidney cancer	2.29e-05	0.000258	CbGpPWpGaD
Furosemide—CA4—Metabolism—PTGS1—kidney cancer	2.29e-05	0.000258	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—RELA—kidney cancer	2.27e-05	0.000256	CbGpPWpGaD
Furosemide—CA6—Metabolism—GSTM1—kidney cancer	2.25e-05	0.000254	CbGpPWpGaD
Furosemide—CA5A—Metabolism—GSTM1—kidney cancer	2.25e-05	0.000254	CbGpPWpGaD
Furosemide—CA1—Metabolism—ACHE—kidney cancer	2.24e-05	0.000253	CbGpPWpGaD
Furosemide—CA1—Metabolism—GSTT1—kidney cancer	2.24e-05	0.000253	CbGpPWpGaD
Furosemide—CA4—Metabolism—PSMD7—kidney cancer	2.24e-05	0.000253	CbGpPWpGaD
Furosemide—PGD—Metabolism—ABCB1—kidney cancer	2.24e-05	0.000253	CbGpPWpGaD
Furosemide—ALB—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	2.22e-05	0.000251	CbGpPWpGaD
Furosemide—CA2—Metabolism—SCARB1—kidney cancer	2.21e-05	0.00025	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—PTGS2—kidney cancer	2.21e-05	0.000249	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.19e-05	0.000248	CbGpPWpGaD
Furosemide—CA2—Metabolism—PTGS1—kidney cancer	2.19e-05	0.000248	CbGpPWpGaD
Furosemide—CA14—Metabolism—CYP1A1—kidney cancer	2.19e-05	0.000248	CbGpPWpGaD
Furosemide—CA9—Cellular responses to stress—MAPK3—kidney cancer	2.19e-05	0.000247	CbGpPWpGaD
Furosemide—PGD—Disease—HIF1A—kidney cancer	2.19e-05	0.000247	CbGpPWpGaD
Furosemide—PGD—Disease—TSC2—kidney cancer	2.18e-05	0.000246	CbGpPWpGaD
Furosemide—PGD—Metabolism—GSTM1—kidney cancer	2.17e-05	0.000245	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—SLC5A5—kidney cancer	2.17e-05	0.000245	CbGpPWpGaD
Furosemide—CA7—Metabolism—ABCB1—kidney cancer	2.17e-05	0.000245	CbGpPWpGaD
Furosemide—CA5B—Metabolism—ABCB1—kidney cancer	2.17e-05	0.000245	CbGpPWpGaD
Furosemide—CA9—Metabolism—ITPR2—kidney cancer	2.16e-05	0.000244	CbGpPWpGaD
Furosemide—CA2—Metabolism—PSMD7—kidney cancer	2.15e-05	0.000243	CbGpPWpGaD
Furosemide—ALB—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	2.15e-05	0.000242	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—ATP7B—kidney cancer	2.14e-05	0.000242	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—ANXA2—kidney cancer	2.14e-05	0.000242	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—SLC5A3—kidney cancer	2.14e-05	0.000242	CbGpPWpGaD
Furosemide—CA6—Metabolism—CYP1A1—kidney cancer	2.14e-05	0.000241	CbGpPWpGaD
Furosemide—CA5A—Metabolism—CYP1A1—kidney cancer	2.14e-05	0.000241	CbGpPWpGaD
Furosemide—CA4—Metabolism—BCHE—kidney cancer	2.12e-05	0.00024	CbGpPWpGaD
Furosemide—CA1—Metabolism—SCARB1—kidney cancer	2.12e-05	0.00024	CbGpPWpGaD
Furosemide—CA12—Metabolism—GSTP1—kidney cancer	2.12e-05	0.000239	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	2.1e-05	0.000238	CbGpPWpGaD
Furosemide—CA7—Metabolism—GSTM1—kidney cancer	2.1e-05	0.000238	CbGpPWpGaD
Furosemide—CA5B—Metabolism—GSTM1—kidney cancer	2.1e-05	0.000238	CbGpPWpGaD
Furosemide—CA1—Metabolism—PTGS1—kidney cancer	2.1e-05	0.000237	CbGpPWpGaD
Furosemide—CA4—Metabolism—SLC5A5—kidney cancer	2.1e-05	0.000237	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—SLC2A1—kidney cancer	2.1e-05	0.000237	CbGpPWpGaD
Furosemide—CA9—Cellular responses to stress—MAPK1—kidney cancer	2.08e-05	0.000235	CbGpPWpGaD
Furosemide—PGD—Metabolism—CYP1A1—kidney cancer	2.06e-05	0.000233	CbGpPWpGaD
Furosemide—CA1—Metabolism—PSMD7—kidney cancer	2.06e-05	0.000233	CbGpPWpGaD
Furosemide—ALB—Hemostasis—KCNMA1—kidney cancer	2.05e-05	0.000232	CbGpPWpGaD
Furosemide—CA2—Metabolism—BCHE—kidney cancer	2.04e-05	0.00023	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	2.03e-05	0.00023	CbGpPWpGaD
Furosemide—CA4—Metabolism—SLC2A1—kidney cancer	2.03e-05	0.000229	CbGpPWpGaD
Furosemide—CA2—Metabolism—SLC5A5—kidney cancer	2.01e-05	0.000227	CbGpPWpGaD
Furosemide—CA12—Metabolism—ABCB1—kidney cancer	2.01e-05	0.000227	CbGpPWpGaD
Furosemide—CA5B—Metabolism—CYP1A1—kidney cancer	1.99e-05	0.000225	CbGpPWpGaD
Furosemide—CA7—Metabolism—CYP1A1—kidney cancer	1.99e-05	0.000225	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.98e-05	0.000224	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—IGF2—kidney cancer	1.98e-05	0.000224	CbGpPWpGaD
Furosemide—CA9—Metabolism—GSTT1—kidney cancer	1.97e-05	0.000223	CbGpPWpGaD
Furosemide—CA9—Metabolism—ACHE—kidney cancer	1.97e-05	0.000223	CbGpPWpGaD
Furosemide—CA1—Metabolism—BCHE—kidney cancer	1.95e-05	0.000221	CbGpPWpGaD
Furosemide—CA12—Metabolism—GSTM1—kidney cancer	1.95e-05	0.00022	CbGpPWpGaD
Furosemide—CA2—Metabolism—SLC2A1—kidney cancer	1.94e-05	0.00022	CbGpPWpGaD
Furosemide—CA1—Metabolism—SLC5A5—kidney cancer	1.93e-05	0.000218	CbGpPWpGaD
Furosemide—PGD—Disease—APC—kidney cancer	1.93e-05	0.000218	CbGpPWpGaD
Furosemide—PGD—Disease—KIT—kidney cancer	1.93e-05	0.000218	CbGpPWpGaD
Furosemide—ALB—Metabolism—ACY1—kidney cancer	1.91e-05	0.000216	CbGpPWpGaD
Furosemide—ALB—Platelet degranulation—VEGFA—kidney cancer	1.88e-05	0.000212	CbGpPWpGaD
Furosemide—CA9—Metabolism—SCARB1—kidney cancer	1.87e-05	0.000211	CbGpPWpGaD
Furosemide—CA1—Metabolism—SLC2A1—kidney cancer	1.86e-05	0.00021	CbGpPWpGaD
Furosemide—CA9—Metabolism—PTGS1—kidney cancer	1.85e-05	0.000209	CbGpPWpGaD
Furosemide—CA12—Metabolism—CYP1A1—kidney cancer	1.85e-05	0.000209	CbGpPWpGaD
Furosemide—PGD—Disease—BRAF—kidney cancer	1.81e-05	0.000205	CbGpPWpGaD
Furosemide—CA9—Metabolism—PSMD7—kidney cancer	1.81e-05	0.000205	CbGpPWpGaD
Furosemide—ALB—Hemostasis—GRB7—kidney cancer	1.79e-05	0.000202	CbGpPWpGaD
Furosemide—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—kidney cancer	1.79e-05	0.000202	CbGpPWpGaD
Furosemide—CA9—Cellular responses to stress—TP53—kidney cancer	1.75e-05	0.000197	CbGpPWpGaD
Furosemide—CA9—Metabolism—BCHE—kidney cancer	1.72e-05	0.000194	CbGpPWpGaD
Furosemide—CA9—Metabolism—SLC5A5—kidney cancer	1.7e-05	0.000192	CbGpPWpGaD
Furosemide—CA4—Metabolism—GSTP1—kidney cancer	1.69e-05	0.000191	CbGpPWpGaD
Furosemide—ALB—Hemostasis—ITPR2—kidney cancer	1.66e-05	0.000188	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.66e-05	0.000187	CbGpPWpGaD
Furosemide—ALB—Folate Metabolism—TP53—kidney cancer	1.65e-05	0.000187	CbGpPWpGaD
Furosemide—CA9—Metabolism—SLC2A1—kidney cancer	1.64e-05	0.000185	CbGpPWpGaD
Furosemide—CA14—Metabolism—POMC—kidney cancer	1.63e-05	0.000185	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	1.63e-05	0.000184	CbGpPWpGaD
Furosemide—ALB—Metabolism—PDHB—kidney cancer	1.62e-05	0.000183	CbGpPWpGaD
Furosemide—CA2—Metabolism—GSTP1—kidney cancer	1.62e-05	0.000183	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.6e-05	0.000181	CbGpPWpGaD
Furosemide—CA4—Metabolism—ABCB1—kidney cancer	1.6e-05	0.000181	CbGpPWpGaD
Furosemide—CA5A—Metabolism—POMC—kidney cancer	1.59e-05	0.00018	CbGpPWpGaD
Furosemide—CA6—Metabolism—POMC—kidney cancer	1.59e-05	0.00018	CbGpPWpGaD
Furosemide—CA1—Metabolism—GSTP1—kidney cancer	1.55e-05	0.000176	CbGpPWpGaD
Furosemide—CA4—Metabolism—GSTM1—kidney cancer	1.55e-05	0.000175	CbGpPWpGaD
Furosemide—PGD—Metabolism—POMC—kidney cancer	1.54e-05	0.000174	CbGpPWpGaD
Furosemide—CA2—Metabolism—ABCB1—kidney cancer	1.53e-05	0.000173	CbGpPWpGaD
Furosemide—ALB—Metabolism—CCBL1—kidney cancer	1.53e-05	0.000172	CbGpPWpGaD
Furosemide—PGD—Disease—RAF1—kidney cancer	1.51e-05	0.000171	CbGpPWpGaD
Furosemide—PGD—Disease—ERBB2—kidney cancer	1.5e-05	0.000169	CbGpPWpGaD
Furosemide—CA2—Metabolism—GSTM1—kidney cancer	1.49e-05	0.000168	CbGpPWpGaD
Furosemide—CA5B—Metabolism—POMC—kidney cancer	1.49e-05	0.000168	CbGpPWpGaD
Furosemide—CA7—Metabolism—POMC—kidney cancer	1.49e-05	0.000168	CbGpPWpGaD
Furosemide—PGD—Disease—MTOR—kidney cancer	1.48e-05	0.000167	CbGpPWpGaD
Furosemide—PGD—Disease—CD4—kidney cancer	1.47e-05	0.000166	CbGpPWpGaD
Furosemide—CA4—Metabolism—CYP1A1—kidney cancer	1.47e-05	0.000166	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—RAF1—kidney cancer	1.47e-05	0.000166	CbGpPWpGaD
Furosemide—CA1—Metabolism—ABCB1—kidney cancer	1.47e-05	0.000166	CbGpPWpGaD
Furosemide—PGD—Disease—PTGS2—kidney cancer	1.46e-05	0.000165	CbGpPWpGaD
Furosemide—CA1—Metabolism—GSTM1—kidney cancer	1.43e-05	0.000161	CbGpPWpGaD
Furosemide—CA2—Metabolism—CYP1A1—kidney cancer	1.41e-05	0.00016	CbGpPWpGaD
Furosemide—PGD—Disease—CDKN1B—kidney cancer	1.39e-05	0.000157	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.38e-05	0.000156	CbGpPWpGaD
Furosemide—CA12—Metabolism—POMC—kidney cancer	1.38e-05	0.000156	CbGpPWpGaD
Furosemide—CA9—Metabolism—GSTP1—kidney cancer	1.37e-05	0.000154	CbGpPWpGaD
Furosemide—CA1—Metabolism—CYP1A1—kidney cancer	1.35e-05	0.000153	CbGpPWpGaD
Furosemide—ALB—Metabolism—GLIPR1—kidney cancer	1.32e-05	0.000149	CbGpPWpGaD
Furosemide—ALB—Metabolism—PPAT—kidney cancer	1.32e-05	0.000149	CbGpPWpGaD
Furosemide—PGD—Disease—CTNNB1—kidney cancer	1.31e-05	0.000148	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.31e-05	0.000148	CbGpPWpGaD
Furosemide—CA14—Metabolism—PTGS2—kidney cancer	1.3e-05	0.000147	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.29e-05	0.000146	CbGpPWpGaD
Furosemide—CA9—Metabolism—ABCB1—kidney cancer	1.29e-05	0.000146	CbGpPWpGaD
Furosemide—PGD—Disease—PTEN—kidney cancer	1.28e-05	0.000144	CbGpPWpGaD
Furosemide—CA6—Metabolism—PTGS2—kidney cancer	1.27e-05	0.000143	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PTGS2—kidney cancer	1.27e-05	0.000143	CbGpPWpGaD
Furosemide—CA9—Metabolism—GSTM1—kidney cancer	1.26e-05	0.000142	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—RAF1—kidney cancer	1.24e-05	0.00014	CbGpPWpGaD
Furosemide—ALB—Metabolism—APRT—kidney cancer	1.23e-05	0.000139	CbGpPWpGaD
Furosemide—ALB—Metabolism—FH—kidney cancer	1.23e-05	0.000139	CbGpPWpGaD
Furosemide—PGD—Metabolism—PTGS2—kidney cancer	1.23e-05	0.000138	CbGpPWpGaD
Furosemide—ALB—Hemostasis—IFNA1—kidney cancer	1.22e-05	0.000138	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.2e-05	0.000136	CbGpPWpGaD
Furosemide—CA9—Metabolism—CYP1A1—kidney cancer	1.19e-05	0.000134	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PTGS2—kidney cancer	1.19e-05	0.000134	CbGpPWpGaD
Furosemide—CA7—Metabolism—PTGS2—kidney cancer	1.19e-05	0.000134	CbGpPWpGaD
Furosemide—ALB—Metabolism—GPC3—kidney cancer	1.16e-05	0.000131	CbGpPWpGaD
Furosemide—CA14—Metabolism—PTEN—kidney cancer	1.14e-05	0.000128	CbGpPWpGaD
Furosemide—ALB—Hemostasis—IFNA2—kidney cancer	1.14e-05	0.000128	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—SLC5A5—kidney cancer	1.13e-05	0.000128	CbGpPWpGaD
Furosemide—ALB—Metabolism—CA2—kidney cancer	1.13e-05	0.000127	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—RAF1—kidney cancer	1.12e-05	0.000127	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PTEN—kidney cancer	1.11e-05	0.000125	CbGpPWpGaD
Furosemide—CA6—Metabolism—PTEN—kidney cancer	1.11e-05	0.000125	CbGpPWpGaD
Furosemide—CA12—Metabolism—PTGS2—kidney cancer	1.1e-05	0.000124	CbGpPWpGaD
Furosemide—CA4—Metabolism—POMC—kidney cancer	1.1e-05	0.000124	CbGpPWpGaD
Furosemide—ALB—Metabolism—ALAD—kidney cancer	1.1e-05	0.000124	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—RAF1—kidney cancer	1.09e-05	0.000123	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—SLC2A1—kidney cancer	1.09e-05	0.000123	CbGpPWpGaD
Furosemide—PGD—Disease—MAPK3—kidney cancer	1.09e-05	0.000123	CbGpPWpGaD
Furosemide—ALB—Metabolism—ST3GAL2—kidney cancer	1.07e-05	0.000121	CbGpPWpGaD
Furosemide—PGD—Metabolism—PTEN—kidney cancer	1.07e-05	0.000121	CbGpPWpGaD
Furosemide—PGD—Disease—MYC—kidney cancer	1.06e-05	0.00012	CbGpPWpGaD
Furosemide—CA2—Metabolism—POMC—kidney cancer	1.05e-05	0.000119	CbGpPWpGaD
Furosemide—ALB—Metabolism—ALDH1A1—kidney cancer	1.05e-05	0.000118	CbGpPWpGaD
Furosemide—PGD—Disease—MAPK1—kidney cancer	1.04e-05	0.000117	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PTEN—kidney cancer	1.03e-05	0.000117	CbGpPWpGaD
Furosemide—CA7—Metabolism—PTEN—kidney cancer	1.03e-05	0.000117	CbGpPWpGaD
Furosemide—ALB—Hemostasis—IGF2—kidney cancer	1.02e-05	0.000116	CbGpPWpGaD
Furosemide—CA1—Metabolism—POMC—kidney cancer	1.01e-05	0.000114	CbGpPWpGaD
Furosemide—ALB—Metabolism—SLC5A3—kidney cancer	1e-05	0.000113	CbGpPWpGaD
Furosemide—ALB—Metabolism—PGK1—kidney cancer	1e-05	0.000113	CbGpPWpGaD
Furosemide—ALB—Metabolism—LDHB—kidney cancer	9.83e-06	0.000111	CbGpPWpGaD
Furosemide—PGD—Disease—KRAS—kidney cancer	9.8e-06	0.000111	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—IL2—kidney cancer	9.79e-06	0.000111	CbGpPWpGaD
Furosemide—CA12—Metabolism—PTEN—kidney cancer	9.58e-06	0.000108	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—RAF1—kidney cancer	9.37e-06	0.000106	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—RAF1—kidney cancer	9.08e-06	0.000103	CbGpPWpGaD
Furosemide—PGD—Disease—PIK3CA—kidney cancer	9e-06	0.000102	CbGpPWpGaD
Furosemide—CA9—Metabolism—POMC—kidney cancer	8.87e-06	0.0001	CbGpPWpGaD
Furosemide—CA4—Metabolism—PTGS2—kidney cancer	8.76e-06	9.89e-05	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—ABCB1—kidney cancer	8.61e-06	9.73e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CA9—kidney cancer	8.53e-06	9.63e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—PTGS2—kidney cancer	8.4e-06	9.49e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	8.33e-06	9.41e-05	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	8.32e-06	9.4e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—PTGS2—kidney cancer	8.05e-06	9.09e-05	CbGpPWpGaD
Furosemide—CA14—Metabolism—PIK3CA—kidney cancer	8.02e-06	9.06e-05	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	7.87e-06	8.89e-05	CbGpPWpGaD
Furosemide—CA6—Metabolism—PIK3CA—kidney cancer	7.81e-06	8.83e-05	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PIK3CA—kidney cancer	7.81e-06	8.83e-05	CbGpPWpGaD
Furosemide—CA4—Metabolism—PTEN—kidney cancer	7.64e-06	8.63e-05	CbGpPWpGaD
Furosemide—PGD—Metabolism—PIK3CA—kidney cancer	7.54e-06	8.51e-05	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	7.49e-06	8.46e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—PTEN—kidney cancer	7.32e-06	8.27e-05	CbGpPWpGaD
Furosemide—CA7—Metabolism—PIK3CA—kidney cancer	7.29e-06	8.24e-05	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PIK3CA—kidney cancer	7.29e-06	8.24e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CRABP1—kidney cancer	7.25e-06	8.19e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—PTGS2—kidney cancer	7.08e-06	7.99e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—PTEN—kidney cancer	7.02e-06	7.93e-05	CbGpPWpGaD
Furosemide—CA12—Metabolism—PIK3CA—kidney cancer	6.76e-06	7.63e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—ITPR2—kidney cancer	6.74e-06	7.61e-05	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	6.5e-06	7.34e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—POMC—kidney cancer	6.21e-06	7.02e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—PTEN—kidney cancer	6.17e-06	6.97e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—GSTT1—kidney cancer	6.15e-06	6.94e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—ACHE—kidney cancer	6.15e-06	6.94e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—SCARB1—kidney cancer	5.82e-06	6.57e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PTGS1—kidney cancer	5.76e-06	6.51e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PSMD7—kidney cancer	5.65e-06	6.38e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—RAF1—kidney cancer	5.63e-06	6.36e-05	CbGpPWpGaD
Furosemide—CA4—Metabolism—PIK3CA—kidney cancer	5.39e-06	6.09e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—BCHE—kidney cancer	5.35e-06	6.05e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—SLC5A5—kidney cancer	5.29e-06	5.97e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—PIK3CA—kidney cancer	5.17e-06	5.84e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—SLC2A1—kidney cancer	5.11e-06	5.77e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—IL2—kidney cancer	5.05e-06	5.7e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.96e-06	5.6e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—PIK3CA—kidney cancer	4.95e-06	5.59e-05	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—RAF1—kidney cancer	4.87e-06	5.5e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—PIK3CA—kidney cancer	4.35e-06	4.92e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.32e-06	4.88e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—VEGFA—kidney cancer	4.29e-06	4.84e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—GSTP1—kidney cancer	4.26e-06	4.81e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—MAPK3—kidney cancer	4.06e-06	4.58e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—ABCB1—kidney cancer	4.03e-06	4.56e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—GSTM1—kidney cancer	3.92e-06	4.42e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—MAPK1—kidney cancer	3.86e-06	4.36e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CYP1A1—kidney cancer	3.71e-06	4.19e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—KRAS—kidney cancer	3.65e-06	4.12e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PIK3CA—kidney cancer	3.35e-06	3.78e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—TP53—kidney cancer	3.24e-06	3.66e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.05e-06	3.44e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—POMC—kidney cancer	2.77e-06	3.13e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PTGS2—kidney cancer	2.21e-06	2.49e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PTEN—kidney cancer	1.92e-06	2.17e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PIK3CA—kidney cancer	1.36e-06	1.53e-05	CbGpPWpGaD
